background
compar
respiratori
virus
rel
littl
known
clinic
impact
coronaviru
cov
infect
hematopoiet
stem
cell
transplant
hsct
patient
hematolog
malign
object
character
role
cov
respiratori
tract
infect
among
hsct
hematolog
malign
patient
studi
design
conduct
retrospect
review
case
cov
infect
document
polymeras
chain
reaction
pcr
base
test
nasopharyng
bronchoalveolar
lavag
fluid
sampl
june
case
cov
infect
occur
hsct
hematolog
malign
patient
identifi
clinic
characterist
case
compar
respiratori
virus
result
cov
identifi
n
sampl
analyz
n
sampl
test
posit
respiratori
viru
n
patient
cov
identifi
hsct
hematolog
malign
patient
among
patient
cov
detect
uniqu
infect
episod
rhinovirusenteroviru
rhvenv
infect
common
group
cov
subtyp
account
case
infect
diagnos
decemb
march
cov
infect
associ
upper
respiratori
tract
symptom
patient
similar
respiratori
virus
possibl
proven
lower
respiratori
tract
diseas
less
common
compar
respiratori
virus
except
rhvenv
conclus
cov
frequent
detect
hsct
hematolog
malign
patient
suspicion
respiratori
viral
infect
exist
less
like
progress
lower
respiratori
tract
diseas
respiratori
virus
clinic
signific
respiratori
virus
influenza
respiratori
syncyti
viru
rsv
parainfluenza
virus
piv
human
metapneumoviru
hmpv
rhinoviru
rhv
adenoviru
adv
patient
hematolog
malign
recipi
autolog
allogen
hematopoiet
stem
cell
transplant
hsct
well
describ
far
less
data
publish
specif
address
impact
coronaviru
cov
infect
patient
lower
respiratori
tract
diseas
lrtd
due
cov
describ
casereport
level
retrospect
analysi
bronchoalveolar
lavag
bal
sampl
obtain
hsct
recipi
acut
pulmonari
process
identifi
cov
sampl
later
prospect
surveil
studi
allogen
hsct
recipi
perform
singl
center
cours
one
year
found
rel
high
cumul
incid
cov
infect
first
day
follow
allogen
hsct
one
case
cov
detect
lower
respiratori
tract
sampl
seri
studi
impact
respiratori
viral
infect
specif
directli
assess
clinic
impact
cov
patient
hematolog
malign
hsct
recipi
appar
high
frequenc
infect
rel
pauciti
inform
pertain
impact
cov
patient
hematolog
malign
hsct
recipi
conduct
retrospect
review
cov
infect
institut
three
year
period
order
character
role
cov
respiratori
tract
infect
patient
nasopharyng
np
bal
sampl
submit
outpati
clinic
inpati
ward
respiratori
viru
test
june
juli
oregon
health
scienc
univers
ohsu
includ
studi
demograph
clinic
inform
pertain
patient
test
posit
cov
respiratori
virus
assay
part
multiplex
pcr
panel
describ
obtain
medic
chart
review
patient
consid
hematolog
malign
diagnos
receiv
treatment
type
leukemia
lymphoma
multipl
myeloma
aplast
anemia
mastocytosi
myelodysplast
syndrom
amyloidosi
patient
underw
allogen
autolog
hsct
cord
blood
transplant
cbt
includ
classifi
regardless
underli
diseas
necessit
transplant
test
perform
use
multiplex
respiratori
viru
pcr
panel
assay
xtag
rvp
luminex
per
manufactur
instruct
sinc
assay
distinguish
rhv
enteroviru
env
result
group
togeth
analysi
cov
pcr
reagent
includ
rvp
test
kit
valid
clinic
test
colleg
american
pathologist
cap
clinic
laboratori
improv
amend
clia
regulatori
condit
ohsu
molecular
diagnost
lab
uniqu
episod
infect
count
initi
identif
respiratori
viru
np
bal
sampl
respiratori
viru
identifi
multipl
consecut
sampl
patient
without
interim
neg
test
result
consid
repres
prolong
shed
therefor
count
singl
uniqu
episod
infect
mortal
attribut
respiratori
viru
infect
death
due
respiratori
failur
without
identif
caus
respiratori
viru
respiratori
viru
inpatientacquir
infect
defin
onset
new
symptom
day
admiss
inpati
ward
criteria
possibl
proven
lrtd
identif
respiratori
viru
np
sampl
possibl
lrtd
bal
sampl
proven
lrtd
along
new
pulmonari
infiltr
thorac
imag
comparison
categor
variabl
viral
group
perform
use
twotail
fisher
exact
test
total
np
bal
sampl
obtain
gener
hospit
inpati
outpati
popul
inclus
limit
hsct
recipi
hematolog
malign
patientswer
analyz
sampl
submit
uniqu
episod
infect
test
posit
respiratori
viru
tabl
cov
third
mostcommon
viru
identifi
rhvenv
account
posit
sampl
three
bal
specimen
posit
cov
see
repres
covposit
sampl
uniqu
episod
infect
hematolog
malign
hsct
patient
popul
tabl
cov
identifi
episod
among
patient
episod
among
hematolog
malign
hsct
patient
episod
cov
infect
hsct
hematolog
malign
popul
diagnos
winter
month
decembermarch
fig
sampl
hematolog
malign
hsct
patient
test
posit
cov
major
group
subtyp
n
n
compar
group
ii
subtyp
n
n
cov
posit
sampl
posit
cov
sampl
coinfect
rhv
rsv
hmpv
rsv
adv
order
better
defin
role
cov
respiratori
tract
syndrom
among
patient
hematolog
malign
hsct
recipi
limit
clinic
analysi
patient
infect
cov
exclud
coinfect
respiratori
virus
tabl
patient
infect
cov
underli
hematolog
malign
n
undergon
allogen
n
autolog
n
hsct
clinic
characterist
cov
infect
patient
examin
compar
episod
monoinfect
respiratori
virus
hmpv
rsv
rhvenv
patient
popul
median
age
infect
cov
similar
respiratori
virus
analyz
surprisingli
cov
identifi
significantli
often
femal
male
compar
hmpv
rhvenv
trend
toward
find
rsv
five
episod
cov
infect
hospitalacquir
four
case
subtyp
occur
inpati
hsctoncolog
ward
within
day
period
januari
march
indic
epidemiolog
link
unabl
conclus
prove
accord
surveil
perform
part
ohsu
infect
control
program
time
period
two
case
nosocomi
acquisit
respiratori
viru
occur
ward
one
rhvenv
one
influenza
person
commun
dr
lynn
strasfeld
case
acquir
outpati
requir
admiss
hospit
typic
evalu
fever
new
pulmonari
infiltr
requir
hospit
cov
infect
significantli
differ
infect
respiratori
virus
similar
respiratori
virus
major
patient
cov
detect
uri
symptom
rhinorrhea
congest
sore
throat
howev
evid
lrtd
cough
new
radiograph
abnorm
observ
less
frequent
cov
infect
trend
toward
less
hypoxemia
well
three
patient
allogen
hsct
recipi
met
criteria
possibl
cov
lrtd
tabl
base
identif
cov
np
specimen
new
radiograph
abnorm
significantli
less
infect
respiratori
virus
except
rhvenv
none
patient
underw
bronchoscopi
two
patient
allogen
hsct
recipi
met
criteria
proven
lrtd
base
identif
cov
bal
sampl
along
new
radiograph
abnorm
tabl
howev
one
patient
also
rsv
adv
methicillinresist
staphylococcu
aureu
identifi
bal
specimen
make
contribut
cov
lrtd
unclear
combin
incid
possibl
proven
lrtd
significantli
lower
cov
infect
compar
respiratori
virus
analyz
except
rhvenv
four
five
case
possibl
proven
lrtd
occur
day
follow
hsct
five
associ
acut
chronic
graftversushost
diseas
gvhd
third
episod
proven
lrtd
account
third
covposit
bal
tabl
occur
patient
undergon
hsct
underli
hematolog
malign
characterist
case
therefor
analyz
case
mortal
directli
attribut
cov
infect
result
present
complement
expand
upon
exist
studi
evalu
role
cov
infect
immunocompromis
host
cov
primarili
group
subtyp
frequent
identifi
hsct
hematolog
malign
popul
suspicion
respiratori
viral
infect
prompt
diagnost
test
popul
cov
infect
associ
similar
rate
uri
symptom
nosocomi
acquisit
requir
hospit
admiss
compar
respiratori
virus
howev
cov
infect
result
less
possibl
proven
lrtd
respiratori
virus
except
rhvenv
frequenc
detect
cov
among
sampl
test
studi
consist
previou
report
cov
detect
patient
hospit
respiratori
syndrom
howev
result
may
reflect
true
preval
cov
infect
patient
routin
screen
asymptomat
patient
would
like
increas
preval
infect
due
detect
asymptomat
shedder
also
import
note
true
rate
influenza
b
infect
underrepres
result
sinc
initi
test
choic
pathogen
institut
influenzaspecif
pcr
assay
respiratori
viru
panel
use
studi
account
would
reduc
rel
frequenc
cov
well
noninfluenza
respiratori
virus
found
hematolog
malign
hsct
popul
account
major
patient
test
posit
cov
respiratori
virus
find
almost
certainli
reflect
test
bia
patient
like
test
respiratori
virus
symptomat
given
import
place
pathogen
interestingli
also
found
femalepredomin
gender
distribut
among
infect
cov
best
knowledg
report
frequenc
respiratori
ill
gener
popul
describ
higher
among
femal
perhap
due
increas
exposur
respons
higher
burden
cov
infect
among
women
compar
men
similar
pattern
might
expect
respiratori
virus
well
find
requir
confirm
addit
studi
major
cov
identifi
hematolog
malign
hsct
patient
studi
belong
group
similarli
group
cov
associ
infect
immunocompromis
host
group
ii
cov
sever
seri
case
report
contrast
studi
involv
gener
pediatr
patient
popul
report
major
cov
belong
group
ii
group
ii
cov
differ
mechan
viru
entri
host
cell
degre
genet
variabl
whether
differ
affect
pathogen
known
inde
report
associ
cov
subtyp
diseas
manifest
conflict
studi
rel
incid
cov
subtyp
among
variou
patient
popul
necessari
may
provid
insight
fundament
biolog
differ
group
ii
subtyp
similar
previou
report
rate
covproven
lrtd
low
significantli
differ
respiratori
virus
howev
result
must
interpret
caution
sinc
bronchoscopi
use
criteria
defin
proven
lrtd
longer
done
mani
case
respiratori
viru
identifi
upper
airway
sampl
institut
other
analyz
possibl
lrtd
instead
cov
inde
associ
significantli
less
diseas
compar
respiratori
virus
analyz
except
rhvenv
rate
possibl
lrtd
due
respiratori
virus
report
gener
consist
publish
literatur
howev
patient
radiographi
perform
time
diagnosi
respiratori
viral
infect
may
bia
result
toward
like
evid
lower
respiratori
tract
ill
interestingli
case
possibl
proven
covassoci
lrtd
occur
hsct
recipi
wherea
case
possibl
proven
lrtd
infect
respiratori
virus
divid
evenli
among
hsct
recipi
hematolog
malign
patient
addit
case
occur
set
acut
chronic
gvhd
taken
togeth
find
suggest
cov
may
inher
less
virul
compar
respiratori
virus
therefor
requir
augment
immun
suppress
hsct
order
progress
lrtd
low
number
covassoci
lrtd
studi
preclud
meaning
risk
factor
assess
addit
studi
may
make
feasibl
asid
lrtd
cov
infect
associ
clinicallyrelev
consequ
name
outpati
admit
hospit
base
manifest
cov
infect
hospit
acquisit
occur
case
cluster
nosocomiallyacquir
case
occur
within
month
span
addit
covinfect
patient
receiv
empir
cours
antibacteri
therapi
data
shown
notabl
cov
detect
part
respiratori
viru
panel
use
institut
studi
period
cov
result
report
medic
record
sinc
assay
approv
food
drug
administr
purpos
theori
neg
respiratori
viru
panel
result
may
lead
frequent
admiss
hospit
medic
evalu
antibacteri
use
nosocomi
transmiss
howev
found
rate
event
cov
infect
similar
infect
respiratori
virus
tabl
data
shown
highlight
overal
impact
respiratori
viral
infect
patient
term
util
medic
resourc
conclus
found
cov
detect
frequent
patient
hematolog
malign
hsct
recipi
suspicion
respiratori
viral
infect
exist
associ
less
lrtd
respiratori
virus
except
rhvenv
retrospect
natur
work
mandat
confirm
find
addit
prospect
studi
